1,3-Benzodioxolyl-N-methylpentanamine

From WikiMD's WELLNESSPEDIA


Chemical structure of 1,3-Benzodioxolyl-N-methylpentanamine

1,3-Benzodioxolyl-N-methylpentanamine, also known as MBDP, is a synthetic compound that belongs to the class of substituted amphetamines. It is structurally related to MDMA and other phenethylamines, and it is known for its psychoactive properties.

Chemical Structure[edit]

MBDP is characterized by the presence of a methylenedioxy group attached to the phenyl ring, which is a common feature in many psychoactive compounds. The chemical structure of MBDP can be described as a phenethylamine core with a methylenedioxy bridge and an N-methylpentanamine side chain.

Pharmacology[edit]

MBDP acts primarily as a serotonin and dopamine releasing agent. It is thought to increase the levels of these neurotransmitters in the brain, leading to its psychoactive effects. The compound is known to produce effects similar to those of MDMA, including euphoria, increased sociability, and enhanced sensory perception.

Effects and Risks[edit]

The effects of MBDP are similar to those of other entactogens, with users reporting feelings of empathy, emotional closeness, and a heightened sense of well-being. However, like many synthetic drugs, MBDP can also pose significant health risks. Potential adverse effects include tachycardia, hypertension, hyperthermia, and serotonin syndrome.

Legal Status[edit]

The legal status of MBDP varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. It is important for researchers and users to be aware of the legal implications of possessing or distributing MBDP.

Related Compounds[edit]

MBDP is part of a larger family of compounds known as substituted methylenedioxyphenethylamines. Other related compounds include MDMA, MDA, and MDEA. These compounds share similar chemical structures and pharmacological effects.

See Also[edit]

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=1,3-Benzodioxolyl-N-methylpentanamine&oldid=6622378"